Literature DB >> 21074071

[Current clinical practice guidelines in type 2 diabetes: how should they be applied in primary care?].

Jorge Navarro Pérez1, Alejandro Navarro Adam, Domingo Orozco Beltrán, Vicente Gil Guillén, Concepción Carratalá Munuera.   

Abstract

Clinical practice guidelines should be drawn up with systematic methodology based on the best available evidence. Recommendations should be based on evaluation of the overall quality of the evidence and grading of the strength of recommendations. Consensus documents combine a review of the evidence with expert opinion in an attempt to reach some agreement in areas of uncertainty due to the lack of conclusive proof. The debate aroused by new treatments stimulates the production of documents advocating their use even when there are few long-term studies on their safety and efficacy. There are several methodologically rigorous international guidelines on diabetes (NGC, NICE, SIGN, CAD, ADA). The most recent debate has centered on the ADA-EASD treatment algorithm. In Spain, the production of clinical practice guidelines with analysis of the evidence and grading of recommendations remains scarce, although the most recent published guidelines show greater rigor. More common is the drafting of consensus documents by scientific societies with the aim of combining external evidence with experience and reflection. In Spain there are also organisms (such as GuíaSalud or Fisterra) that facilitate free access to guidelines drawn up by Spanish groups.
Copyright © 2010 Elsevier España, S.L. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21074071      PMCID: PMC8171389          DOI: 10.1016/S0212-6567(10)70003-2

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


  7 in total

1.  [The COMBO project. Criteria and guidelines for the combined treatment of type 2 diabetes. Consensus document (I)].

Authors:  A Goday Arno; J Franch Nadal; M Mata Cases
Journal:  Aten Primaria       Date:  2001-02-28       Impact factor: 1.137

2.  [Are the guidelines guiding us reliable? Evaluation of the Spanish clinical practice guidelines].

Authors:  M A Navarro Puerto; F Ruiz Romero; A Reyes Domínguez; I Gutiérrez Ibarlucea; T Hermosilla Gago; C Alonso Ortiz del Río; R Rico Iturrioz; J Asúa Batarrita
Journal:  Rev Clin Esp       Date:  2005-11       Impact factor: 1.556

3.  Standards of medical care in diabetes--2010.

Authors: 
Journal:  Diabetes Care       Date:  2010-01       Impact factor: 19.112

4.  [SEN-SEMFYC consensus document on chronic kidney disease].

Authors:  R Alcázar; M I Egocheaga; L Orte; J M Lobos; E González Parra; F Alvarez Guisasola; J L Górriz; J F Navarro; A L Martín de Francisco
Journal:  Nefrologia       Date:  2008       Impact factor: 2.033

5.  [European Guidelines on Cardiovascular Disease Prevention in Clinical Practice. CEIPC 2008 Spanish Adaptation].

Authors:  José M A Lobos Bejarano; Miguel Angel Royo-Bordonada; Carlos Brotons; Luís Alvarez-Sala; Pedro Armario; Antonio Maiques; Dídac Mauricio; Susana Sans; Fernando Villar; Angel Lizcano; Antonio Gil-Núñez; Fernando de Alvaro; Pedro Conthe; Emilio Luengo; Alfonso Del Río; Olga Cortés; Ana de Santiago; Miguel A Vargas; Mercedes Martínez; Vicenta Lizarbe
Journal:  Aten Primaria       Date:  2009-07-15       Impact factor: 1.137

6.  Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control.

Authors:  Helena W Rodbard; Paul S Jellinger; Jaime A Davidson; Daniel Einhorn; Alan J Garber; George Grunberger; Yehuda Handelsman; Edward S Horton; Harold Lebovitz; Philip Levy; Etie S Moghissi; Stanley S Schwartz
Journal:  Endocr Pract       Date:  2009 Sep-Oct       Impact factor: 3.443

7.  Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  David M Nathan; John B Buse; Mayer B Davidson; Ele Ferrannini; Rury R Holman; Robert Sherwin; Bernard Zinman
Journal:  Diabetes Care       Date:  2008-10-22       Impact factor: 17.152

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.